Bangladesh vs Cambodia: Prevalence rate of obesity in adults
Bangladesh
5.8%
in 2024
Cambodia
4.9%
in 2024
Bangladesh rank
191st
Cambodia rank
194th
Prevalence rate of obesity in adults over time
- Bangladesh
- Cambodia
How they compare
Bangladesh currently reports 5.8% against 4.9% in Cambodia, a difference of 0.9%.
That makes Bangladesh's figure about 1.2 times Cambodia's.
The two have swapped places 1 time across 45 shared years of data; in 1980 it was Cambodia ahead.
Bangladesh ranks 191st and Cambodia ranks 194th of 199 countries.
Across the 5 decades both report, Bangladesh averaged higher in 2 and Cambodia in 3.
Head to head by decade
| Decade | Bangladesh | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 0.2% | 0.4% | 0.2% | Cambodia |
| 1990s | 0.5% | 0.7% | 0.2% | Cambodia |
| 2000s | 1.3% | 1.4% | 0.0% | Cambodia |
| 2010s | 3.2% | 2.7% | 0.4% | Bangladesh |
| 2020s | 5.1% | 4.4% | 0.8% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Bangladesh or Cambodia?
- Bangladesh, at 5.8% against 4.9% in Cambodia as of 2024.
- What is the difference in prevalence rate of obesity in adults between Bangladesh and Cambodia?
- 0.9%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Cambodia?
- 45 years are reported by both, from 1980 to 2024.
- How do Bangladesh and Cambodia rank globally for prevalence rate of obesity in adults?
- Bangladesh ranks 191st and Cambodia ranks 194th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) β with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.